August 24, 2025 a 08:38 am
LH: Analysts Ratings - Labcorp Holdings Inc.
Labcorp Holdings Inc., known for providing comprehensive laboratory services, has demonstrated stability in market evaluations. Recent analyst trends indicate a predominantly positive sentiment with a significant portion of ratings as 'Buy' or higher, reflecting the company's solid performance and continued investor confidence. However, the slight shift in Strong Buy ratings might suggest a cautious approach among analysts regarding future growth prospects.
Historical Stock Grades
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 12 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment surrounding Labcorp Holdings Inc. has remained largely positive over recent months, with a predominant leaning towards 'Buy' ratings. Notable shifts include a decrease in 'Strong Buy' recommendations since April 2025. The overall rating numbers have seen a slight increase, with a trend towards more conservative 'Hold' ratings in recent months.
- Reduction in 'Strong Buy' opinions over recent months.
- Consistent level of 'Buy' ratings reflecting stable investor confidence.
- Small increase in 'Hold' ratings, suggesting some caution among analysts.
Percentage Trends
The distribution of analyst ratings has shown subtle shifts in the past several months. While 'Strong Buy' ratings have decreased, both 'Buy' and 'Hold' ratings remain dominant. Analysts appear more cautious, perhaps reflecting broader market uncertainties.
- Decrease in 'Strong Buy' from 21% to 13% over the past year.
- 'Buy' ratings show a stable trend, around 60% of the overall opinions.
- Increase in 'Hold' ratings, indicating a trend towards neutrality.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-25 | Overweight | Overweight | Morgan Stanley |
| 2025-07-25 | Buy | Buy | UBS |
| 2025-07-25 | Outperform | Outperform | Evercore ISI Group |
| 2025-07-25 | Outperform | Outperform | Baird |
| 2025-07-25 | Buy | Buy | Truist Securities |
Analyst Recommendations with Change of Opinion
The data indicates several instances where analysts have revised their opinions regarding Labcorp Holdings. Upgrades demonstrate increased confidence, while downgrades highlight areas where caution may be warranted.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-03-04 | Buy | Neutral | Citigroup |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2024-10-30 | Buy | Hold | HSBC |
| 2024-03-25 | Buy | Hold | Argus Research |
| 2022-12-12 | Neutral | Buy | Citigroup |
Interpretation
Analyst sentiment towards Labcorp Holdings remains largely stable, indicating a balanced view of the company's performance and potential. The slight reduction in 'Strong Buy' ratings alludes to potential challenges, perhaps macroeconomic, that may affect future outlooks. Despite this, a consistent number of 'Buy' ratings imply that overall confidence in the company remains intact. The analysis suggests moderate expectations for growth with a measure of caution prevailing among analysts.
Conclusion
Labcorp Holdings Inc. is navigating a nuanced landscape with ratings reflecting both positive sentiment and cautious optimism. The consistency of 'Buy' recommendations highlights resilience, yet, the decrease in 'Strong Buy' ratings and the increase in 'Hold' ratings suggest prudence among analysts. Overall, while growth prospects appeal to investors, potential risks are mitigated through conservative outlooks, affirming Labcorp's position as a stable yet evolving market contender.